Activating transcription factor 4 mediates up-regulation of alanine aminotransferase 2 gene expression under metabolic stress

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 4, 2014, Pages 288-296

  Salgado, María C ^a   Metón, Isidoro ^a   Anemaet, Ida G ^a,b   Baanante, Isabel V ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Activating transcription factor 4; Alanine aminotransferase 1; Alanine aminotransferase 2; Amino acid deprivation; ER stress; Gene knock down

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ALANINE AMINOTRANSFERASE; ALANINE AMINOTRANSFERASE 2; HISTIDINOL; TUNICAMYCIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL LYSATE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METABOLIC STRESS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; START CODON; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSIENT TRANSFECTION; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 4; ALANINE AMINOTRANSFERASE 1; ALANINE AMINOTRANSFERASE 2; AMINO ACID DEPRIVATION; ER STRESS; GENE KNOCK-DOWN;

ACTIVATING TRANSCRIPTION FACTOR 4; ALANINE TRANSAMINASE; AMINO ACIDS; BASE SEQUENCE; CARBOHYDRATE METABOLISM; GENE EXPRESSION REGULATION; HEP G2 CELLS; HISTIDINOL; HUMANS; MITOCHONDRIA; PROMOTER REGIONS, GENETIC; STRESS, PHYSIOLOGICAL;

EID: 84896904824     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.01.005     Document Type: Article

References (59)

1. Sohocki M.M., Sullivan L.S., Harrison W.R., Sodergren E.J., Elder F.F., Weinstock G., Tanase S., Daiger S.P. Human glutamate pyruvate transaminase (GPT): localization to 8q24.3, cDNA and genomic sequences, and polymorphic sites. Genomics 1997, 40:247-252.
2. Yang R.Z., Blaileanu G., Hansen B.C., Shuldiner A.R., Gong D.W. cDNA cloning, genomic structure, chromosomal mapping, and functional expression of a novel human alanine aminotransferase. Genomics 2002, 79:445-450.
3. Yang R.Z., Park S., Reagan W.J., Goldstein R., Zhong S., Lawton M., Rajamohan F., Qian K., Liu L., Gong D.W. Alanine aminotransferase isoenzymes: molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity. Hepatology 2009, 49:598-607.
4. Jadhao S.B., Yang R.Z., Lin Q., Hu H., Anania F.A., Shuldiner A.R., Gong D.W. Murine alanine aminotransferase: cDNA cloning, functional expression, and differential gene regulation in mouse fatty liver. Hepatology 2004, 39:1297-1302.
5. Lindblom P., Rafter I., Copley C., Andersson U., Hedberg J.J., Berg A.L., Samuelsson A., Hellmold H., Cotgreave I., Glinghammar B. Isoforms of alanine aminotransferases in human tissues and serum - differential tissue expression using novel antibodies. Arch. Biochem. Biophys. 2007, 466:66-77.
6. Dufour D.R., Lott J.A., Nolte F.S., Gretch D.R., Koff R.S., Seeff L.B. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin. Chem. 2000, 46:2050-2068.
7. Glinghammar B., Rafter I., Lindstrom A.K., Hedberg J.J., Andersson H.B., Lindblom P., Berg A.L., Cotgreave I. Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma. Int. J. Mol. Med. 2009, 23:621-631.
8. Senior J.R. Alanine aminotransferase: a clinical and regulatory tool for detecting liver injury - past, present, and future. Clin. Pharmacol. Ther. 2012, 92:332-339.
9. Nathwani R.A., Pais S., Reynolds T.B., Kaplowitz N. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 2005, 41:380-382.
10. Wannamethee S.G., Shaper A.G., Lennon L., Whincup P.H. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 2005, 28:2913-2918.
11. West J., Brousil J., Gazis A., Jackson L., Mansell P., Bennett A., Aithal G.P. Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus. QJM 2006, 99:871-876.
12. Iacobellis G., Moschetta A., Buzzetti R., Ribaudo M.C., Baroni M.G., Leonetti F. Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin. Nutr. Metab. Cardiovasc. Dis. 2007, 17:442-447.
13. Schindhelm R.K., Dekker J.M., Nijpels G., Bouter L.M., Stehouwer C.D., Heine R.J., Diamant M. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 2007, 191:391-396.
14. Leeds J.S., Forman E.M., Morley S., Scott A.R., Tesfaye S., Sanders D.S. Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. Diabet. Med. 2009, 26:1235-1241.
15. Lioudaki E., Ganotakis E.S., Mikhailidis D.P. Liver enzymes: potential cardiovascular risk markers?. Curr. Pharm. Des. 2011, 17:3632-3643.
16. McMillan H.J., Gregas M., Darras B.T., Kang P.B. Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy. Pediatrics 2011, 127:e132-e136.
17. Porter S.A., Pedley A., Massaro J.M., Vasan R.S., Hoffmann U., Fox C.S. Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study. Arterioscler. Thromb. Vasc. Biol. 2013, 33:139-146.
18. Vozarova B., Stefan N., Lindsay R.S., Saremi A., Pratley R.E., Bogardus C., Tataranni P.A. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002, 51:1889-1895.
19. Hanley A.J., Williams K., Festa A., Wagenknecht L.E., D'Agostino R.B., Kempf J., Zinman B., Haffner S.M. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2004, 53:2623-2632.
20. Sattar N., McConnachie A., Ford I., Gaw A., Cleland S.J., Forouhi N.G., McFarlane P., Shepherd J., Cobbe S., Packard C. Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes 2007, 56:984-991.
21. Zhang Y., Lu X., Hong J., Chao M., Gu W., Wang W., Ning G. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus. Endocrine 2010, 38:181-187.
22. Park S.H., Heo N.Y., Park J.H., Kim T.O., Yang S.Y., Moon Y.S., Kim C.H., Suk K.T., Kim D.J., Lee H.Y. Obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population. J. Pediatr. Endocrinol. Metab. 2012, 25:945-949.
23. Gray S., Wang B., Orihuela Y., Hong E.G., Fisch S., Haldar S., Cline G.W., Kim J.K., Peroni O.D., Kahn B.B., Jain M.K. Regulation of gluconeogenesis by Kruppel-like factor 15. Cell Metab. 2007, 5:305-312.
24. Takashima M., Ogawa W., Hayashi K., Inoue H., Kinoshita S., Okamoto Y., Sakaue H., Wataoka Y., Emi A., Senga Y., Matsuki Y., Watanabe E., Hiramatsu R., Kasuga M. Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action. Diabetes 2010, 59:1608-1615.
25. Thulin P., Rafter I., Stockling K., Tomkiewicz C., Norjavaara E., Aggerbeck M., Hellmold H., Ehrenborg E., Andersson U., Cotgreave I., Glinghammar B. PPARalpha regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes. Toxicol. Appl. Pharmacol. 2008, 231:1-9.
26. Josekutty J., Iqbal J., Iwawaki T., Kohno K., Hussain M.M. Microsomal triglyceride transfer protein inhibition induces endoplasmic reticulum stress and increases gene transcription via Ire1alpha/cJun to enhance plasma ALT/AST. J. Biol. Chem. 2013, 288:14372-14383.
27. Anemaet I.G., Gonzalez J.D., Salgado M.C., Giralt M., Fernandez F., Baanante I.V., Meton I. Transactivation of cytosolic alanine aminotransferase gene promoter by p300 and c-Myb. J. Mol. Endocrinol. 2010, 45:119-132.
28. Salgado M.C., Meton I., Anemaet I.G., Gonzalez J.D., Fernandez F., Baanante I.V. Hepatocyte nuclear factor 4alpha transactivates the mitochondrial alanine aminotransferase gene in the kidney of Sparus aurata. Mar. Biotechnol. (NY) 2012, 14:46-62.
29. Ameri K., Harris A.L. Activating transcription factor 4. Int. J. Biochem. Cell Biol. 2008, 40:14-21.
30. Hai T.W., Liu F., Coukos W.J., Green M.R. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 1989, 3:2083-2090.
31. Kilberg M.S., Shan J., Su N. ATF4-dependent transcription mediates signaling of amino acid limitation. Trends Endocrinol. Metab. 2009, 20:436-443.
32. Harding H.P., Zhang Y., Zeng H., Novoa I., Lu P.D., Calfon M., Sadri N., Yun C., Popko B., Paules R., Stojdl D.F., Bell J.C., Hettmann T., Leiden J.M., Ron D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 2003, 11:619-633.
33. Ameri K., Lewis C.E., Raida M., Sowter H., Hai T., Harris A.L. Anoxic induction of ATF-4 through HIF-1-independent pathways of protein stabilization in human cancer cells. Blood 2004, 103:1876-1882.
34. Blais J.D., Filipenko V., Bi M., Harding H.P., Ron D., Koumenis C., Wouters B.G., Bell J.C. Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol. Cell. Biol. 2004, 24:7469-7482.
35. Wang C., Xia T., Du Y., Meng Q., Li H., Liu B., Chen S., Guo F. Effects of ATF4 on PGC1alpha expression in brown adipose tissue and metabolic responses to cold stress. Metabolism 2013, 62:282-289.
36. Cullinan S.B., Diehl J.A. Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int. J. Biochem. Cell Biol. 2006, 38:317-332.
37. Adams C.M. Role of the transcription factor ATF4 in the anabolic actions of insulin and the anti-anabolic actions of glucocorticoids. J. Biol. Chem. 2007, 282:16744-16753.
38. Balasubramanian M.N., Butterworth E.A., Kilberg M.S. Asparagine synthetase: regulation by cell stress and involvement in tumor biology. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E789-E799.
39. Xiao G., Zhang T., Yu S., Lee S., Calabuig-Navarro V., Yamauchi J., Ringquist S., Dong H.H. ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice. J. Biol. Chem. 2013, 288:25350-25361.
40. Salgado M.C., Meton I., Egea M., Baanante I.V. Transcriptional regulation of glucose-6-phosphatase catalytic subunit promoter by insulin and glucose in the carnivorous fish, Sparus aurata. J. Mol. Endocrinol. 2004, 33:783-795.
41. Anemaet I.G., Metón I., Salgado M.C., Fernández F., Baanante I.V. A novel alternatively spliced transcript of cytosolic alanine aminotransferase gene associated with enhanced gluconeogenesis in liver of Sparus aurata. Int. J. Biochem. Cell Biol. 2008, 40:2833-2844.
42. Schaefer B.C. Revolutions in rapid amplification of cDNA ends: new strategies for polymerase chain reaction cloning of full-length cDNA ends. Anal. Biochem. 1995, 227:255-273.
43. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M., Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942.
44. Siu F., Bain P.J., LeBlanc-Chaffin R., Chen H., Kilberg M.S. ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene. J. Biol. Chem. 2002, 277:24120-24127.
45. Sato H., Nomura S., Maebara K., Sato K., Tamba M., Bannai S. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation. Biochem. Biophys. Res. Commun. 2004, 325:109-116.
46. Hansen B.S., Vaughan M.H., Wang L. Reversible inhibition by histidinol of protein synthesis in human cells at the activation of histidine. J. Biol. Chem. 1972, 247:3854-3857.
47. Rafter I., Graberg T., Kotronen A., Strommer L., Mattson C.M., Kim R.W., Ehrenborg E., Andersson H.B., Yki-Jarvinen H., Schuppe-Koistinen I., Ekblom B., Cotgreave I., Glinghammar B. Isoform-specific alanine aminotransferase measurement can distinguish hepatic from extrahepatic injury in humans. Int. J. Mol. Med. 2012, 30:1241-1249.
48. Liu R., Pan X., Whitington P.F. Increased hepatic expression is a major determinant of serum alanine aminotransferase elevation in mice with nonalcoholic steatohepatitis. Liver Int. 2009, 29:337-343.
49. Reagan W.J., Yang R.Z., Park S., Goldstein R., Brees D., Gong D.W. Metabolic adaptive ALT isoenzyme response in livers of C57/BL6 mice treated with dexamethasone. Toxicol. Pathol. 2012, 40:1117-1127.
50. Pan Y., Chen H., Siu F., Kilberg M.S. Amino acid deprivation and endoplasmic reticulum stress induce expression of multiple activating transcription factor-3 mRNA species that, when overexpressed in HepG2 cells, modulate transcription by the human asparagine synthetase promoter. J. Biol. Chem. 2003, 278:38402-38412.
51. Lopez A.B., Wang C., Huang C.C., Yaman I., Li Y., Chakravarty K., Johnson P.F., Chiang C.M., Snider M.D., Wek R.C., Hatzoglou M. A feedback transcriptional mechanism controls the level of the arginine/lysine transporter cat-1 during amino acid starvation. Biochem. J. 2007, 402:163-173.
52. Shan J., Ord D., Ord T., Kilberg M.S. Elevated ATF4 expression, in the absence of other signals, is sufficient for transcriptional induction via CCAAT enhancer-binding protein-activating transcription factor response elements. J. Biol. Chem. 2009, 284:21241-21248.
53. Donnelly N., Gorman A.M., Gupta S., Samali A. The eIF2alpha kinases: their structures and functions. Cell. Mol. Life Sci. 2013, 70:3493-3511.
54. Gentile C.L., Nivala A.M., Gonzales J.C., Pfaffenbach K.T., Wang D., Wei Y., Jiang H., Orlicky D.J., Petersen D.R., Pagliassotti M.J., Maclean K.N. Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R1710-R1722.
55. Mendes-Mourao J., Halestrap A.P., Crisp D.M., Pogson C.I. The involvement of mitochondrial pyruvate transport in the pathways of gluconeogenesis from serine and alanine in isolated rat and mouse liver cells. FEBS Lett. 1975, 53:29-32.
56. Quistorff B., Grunnet N. Dual-digitonin-pulse perfusion. Concurrent sampling of periportal and perivenous cytosol of rat liver for determination of metabolites and enzyme activities. Biochem. J. 1987, 243:87-95.
57. Bouman L., Schlierf A., Lutz A.K., Shan J., Deinlein A., Kast J., Galehdar Z., Palmisano V., Patenge N., Berg D., Gasser T., Augustin R., Trumbach D., Irrcher I., Park D.S., Wurst W., Kilberg M.S., Tatzelt J., Winklhofer K.F. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ. 2011, 18:769-782.
58. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 2007, 8:519-529.
59. Teske B.F., Wek S.A., Bunpo P., Cundiff J.K., McClintick J.N., Anthony T.G., Wek R.C. The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress. Mol. Biol. Cell 2011, 22:4390-4405.